4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0000950170-23-015824
Options or other derivatives
- Chief Legal Officer acquired 127,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Oltmans Curtis Gale Chief Legal Officer | 2023-04-26 | Grant or award · Stock Option (right to buy) | +127,500 | 127,500 | D | ||
Loading xslF345X04/ownership.xml…